Production (Stage)
Beta Bionics, Inc.
BBNX
$14.43
-$1.08-6.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 231.47M | 103.58M | 60.90M | 96.75M | |
| Total Receivables | 9.06M | 12.00M | 7.46M | -- | |
| Inventory | 15.73M | 13.32M | 11.29M | -- | |
| Prepaid Expenses | 3.44M | 2.98M | 2.60M | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 2.21M | 1.05M | 305.00K | -- | |
| Total Current Assets | 261.92M | 132.92M | 82.56M | -- | |
|
|
|||||
| Total Current Assets | 261.92M | 132.92M | 82.56M | -- | |
| Net Property, Plant & Equipment | 11.86M | 11.42M | 11.04M | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 246.00K | 5.30M | 3.35M | -- | |
| Total Assets | 338.02M | 149.65M | 96.94M | -- | |
|
|
|||||
| Total Accounts Payable | 3.45M | 2.85M | 2.85M | -- | |
| Total Accrued Expenses | 8.31M | 13.33M | 11.46M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 1.52M | 1.53M | 1.45M | -- | |
| Total Finance Division Other Current Liabilities | 3.21M | 3.44M | 2.12M | -- | |
| Total Other Current Liabilities | 3.21M | 3.44M | 2.12M | -- | |
| Total Current Liabilities | 16.49M | 21.15M | 17.88M | -- | |
|
|
|||||
| Total Current Liabilities | 16.49M | 21.15M | 17.88M | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 5.45M | 5.73M | 5.85M | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 2.33M | 46.76M | 40.34M | -- | |
| Total Liabilities | 24.27M | 73.63M | 64.07M | -- | |
|
|
|||||
| Common Stock & APIC | 638.91M | 51.31M | 49.72M | -- | |
| Retained Earnings | -325.39M | -296.74M | -278.63M | -- | |
| Treasury Stock & Other | 240.00K | 65.00K | 58.00K | -- | |
| Total Common Equity | 313.75M | -245.36M | -228.85M | -203.11M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | 321.37M | 261.71M | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | 321.37M | 261.71M | 261.71M | |
|
|
|||||
| Total Common Equity | 313.75M | -245.36M | -228.85M | -203.11M | |
| Total Preferred Equity | -- | 321.37M | 261.71M | 261.71M | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 313.75M | 76.01M | 32.87M | 58.61M | |
|
|
|||||